Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
SNDK is now down 11% on the week and 9% over the past month, closing at $1,482, yet the short-side thesis continues to lose adherents rather than gain them with 15 days until the October 29 earnings print.
The short-covering story that has defined this stock since early September remains intact. Short interest has fallen again to 3.4% of the free float, down from 3.7% a week ago and from roughly 5.3% at the start of September. In absolute terms, shorts have unwound from nearly 7.8 million shares six weeks ago to just under 5 million today. That is a 35% reduction in short exposure into a stock that has dropped more than 9% over the same period. The lending market offers no friction to new shorts: availability runs at 4,376%, meaning more than 43 shares are available to borrow for every one currently on loan, and the cost to borrow has eased to 0.26%. The ORTEX short score has drifted to 30.7, its lowest reading in recent history. This is orderly covering, not a squeeze, and the covering is happening while the stock falls, which points to conviction-reduction rather than forced exits.
Options positioning has moved slightly less defensive than the recent peak, though puts still dominate. The put/call ratio pulled back to 1.20 from 1.27 last week, and is now running about 1.7 standard deviations below its 20-day average of 1.24. That is a modest shift toward calls at the margin, but the ratio remains above 1.0 and well within the range it has occupied for months. The 52-week high on the PCR is 1.65, so current levels are far from extreme. The options market is cautious, not panicked.
The Street is considerably more optimistic than the price action implies. The analyst consensus sits at a mean price target of $2,173, roughly 47% above Wednesday's close. The most recent move came from Mizuho on October 6, where the firm raised its target from $1,875 to $2,050 while keeping an Outperform rating. Rosenblatt initiated with a Buy and a $2,400 target in September. The bull case centres on NAND's structural shift toward AI inference and data staging, Sandisk's vertical integration with Kioxia, and $93.9 billion of minimum contracted revenue underpinning visibility. Bears point to cyclical NAND exposure, Chinese competitive pressure, and roughly 60% of 2025 sales still tied to edge devices vulnerable to PC and smartphone cycles. The EV/EBITDA multiple has compressed to 4.8, down modestly over 30 days, reflecting the price weakness. The analyst recommendation divergence factor ranks in the 94th percentile of the ORTEX universe, which means the spread between bulls and bears is unusually wide relative to peers, a setup that tends to resolve sharply on a binary catalyst.
Insider activity leans negative but is almost entirely pre-arranged. CEO David Goeckeler sold roughly $9.4 million of stock on September 17 across multiple transactions, all executed under a 10b5-1 plan. The CLO Bernard Shek sold $1 million on October 1, also under a plan. Net insider selling over the past 90 days totals around $117.6 million in value. Planned sales are compensation mechanics as much as conviction signals, but the volume and timing, with the stock then trading near its post-spin highs and now 11% lower, will attract scrutiny heading into earnings. On the institutional side, JP Morgan Asset Management added 2.1 million shares in the most recently reported quarter, one of the larger incremental purchases among top holders.
Earnings history adds further context on what to expect from the print. The last four events produced moves of plus 22%, plus 17%, minus 12%, and minus 12%, with no consistent directional pattern. The two-session average masks the divergence: strong beats produced strong pops, and misses produced sharp drops. With the stock down significantly from its post-spin highs and the analyst consensus implying 47% upside, the October 29 print becomes the clearest test of whether the NAND re-rating thesis is tracking or whether the recent price weakness reflects a more cautious read on the near-term demand picture.
See the live data behind this article on ORTEX.
Open SNDK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
